In 2013, the American Medical Directors Association was involved in identifying the top 5 items that physicians and patients should question in the long-term care setting as part of the American Board of Internal Medicine Foundation’s Choosing Wisely Campaign. Item 4 on this list was “Don’t prescribe antipsychotic medications for behavioral and psychological symptoms of dementia (BPSD) in individuals with dementia

without an assessment for an underlying cause of the behavior.”9 The most recent UK audit of primary care data showed a decrease in antipsychotic prescribing to individuals with dementia from approximately 17% in 2006 to 7% in 2011.10 The audit showed widespread and significant variation in practice across the country, ranging from approximately PCI-32765 nmr 3% of individuals with dementia receiving antipsychotic medication at the time of the audit in London and the southeast to approximately 13% in the northwest. The audit provided no information on duration of prescription or on the residential setting of people with dementia and represents data from approximately 50% of general practices in the United Kingdom. Audit studies based in nursing homes have generally reported a higher prevalence of antipsychotic prescription among individuals with dementia.11, 12, 13 and 14 Anecdotally, we are Torin 1 mw aware

of a variety of interventions being used to assess, evaluate, and review the prescription of antipsychotic medications in care homes. These include education and raising staff awareness, development and use of decision-making pathways, medication checklists, mood, pain and behavioral charts, advice on nondrug-based alternatives, regular medication review by pharmacists, community Cyclooxygenase (COX) or hospital-based psychiatrists and general practitioners, interdisciplinary education programs, and pharmacist-led strategies. The purpose of this systematic review was to assess the effectiveness of interventions used to reduce inappropriate prescribing of antipsychotic medications to individuals with dementia resident in

care homes to help to inform the provision of services. We also were interested in published accounts of the views and experiences of prescribers of included interventions to highlight barriers and facilitators to the successful implementation of such interventions. The systematic review was conducted following the general principles published by the NHS Centre for Reviews and Dissemination (CRD).15 A predefined protocol was developed following consultation with topic and methods experts and is registered with PROSPERO (PROSPERO 2012:CRD42012003425). A comprehensive search syntax using MeSH and free text terms was developed by an information specialist (M.R.) in consultation with the review team (Table 1).